Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -176.00K | -181.00K | -503.10K | -502.00K | -1.56M |
| Total Depreciation and Amortization | 2.50K | 2.60K | 126.60K | 126.40K | 195.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -223.10K | -229.40K | 324.70K | 324.10K | -83.80K |
| Change in Net Operating Assets | 33.70K | 34.60K | -- | -- | 701.60K |
| Cash from Operations | -362.90K | -373.10K | -51.70K | -51.60K | -748.30K |
| Capital Expenditure | -- | -- | -- | -- | -54.40K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 27.60K | 27.50K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 27.60K | 27.50K | -54.40K |
| Total Debt Issued | 250.00K | 250.00K | 110.00K | 110.00K | 500.00K |
| Total Debt Repaid | -21.60K | -21.60K | -- | -- | -211.80K |
| Issuance of Common Stock | 1.56M | 1.56M | -- | -- | 985.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.10K | -96.10K | -- | -- | -138.30K |
| Cash from Financing | 1.10M | 1.14M | 72.50K | 72.30K | 739.50K |
| Foreign Exchange rate Adjustments | 3.90K | 4.00K | 2.80K | 2.80K | -10.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | 745.50K | 766.60K | 51.20K | 51.10K | -73.80K |
